A new clinical study has demonstrated the effectiveness of Nanomedic’s Spincare System for the treatment of wounds and burns.
Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, announced the results of the study, which showed its Spincare System is effective for the treatment of superficial to partial thickness wounds and burns.
The study has been published in Annals of Burns and Fire Disasters, the official publication of the Euro-Mediterranean Council for Burns and Fire Disasters and the European Burns Association.
The single-centre prospective observational trial revealed that the Spincare polymer nanofibrous dressing (PND) allows for a maximum range of motion, is suitable for covering all wound types and attaches well on to wound surfaces throughout the entire healing period.
Principal author, Dr Alexandra Schulz, who performed the study at the Cologne-Merheim Medical Center in Germany, said: “As electrospinning technology has recently gained increased attention, we were eager to explore the potential use of the new Spincare System for treating a range of burns and wounds. We found the system easy to use and were pleased to see that the nanofibrous layer is suitable for multiple cases, including following enzymatic debridement in burn wounds, yielding promising results for the treatment of superficial to partial thickness wounds.”
The clinical study took place over four months, and evaluated treatment results from 10 patients aged between 19 and 76. The subjects treated suffered from superficial to partial thickness wounds including split-thickness donor sites burns.
Treatment was evaluated, including procedures, place of injury, treatment times, and ease of use. The PND was applied between the day of injury and up to 21 days post-injury and no adverse events or signs of infection were found in any cases treated.
Dr Chen Barak, Chief Executive Officer of Nanomedic, said: “We are encouraged by these study results evaluating Spincare’s ease of use and efficacy on human donor sites and burn wounds. Our solution provides an easy one-time application for improved treatment of wounds, while allowing patients to quickly return to active life, with improved mobility and excellent healing and scarring. We are pleased that the Cologne-Merheim Medical Center has tested our device and are working on additional clinical studies with medical facilities across the globe.”
The next steps of the evaluation will be presented in a few months and will include treatment of superficial to partial thickness burns with PND on a larger scale, with emphasis placed on healing time and long-term scarring.